Literature DB >> 23543244

Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review.

Andrea Salmaggi1, Giorgia Simonetti, Elisa Trevisan, Deirdre Beecher, Carmine Maria Carapella, Francesco DiMeco, Laura Conti, Andrea Pace, Graziella Filippini.   

Abstract

Venous thromboembolism (VTE) events are frequent in neurooncological patients in perioperative period thus increasing mortality and morbidity. The role of prophylaxis has not yet been established with certainty, and in various neurosurgery and intensive care units the practice is inconsistent. A better definition of the risk/cost/benefit ratio of the various methods, both mechanical (intermittent pneumatic compression-IPC, graduated compression stockings-GCS) and pharmacological (unfractionated heparin-UFH or low molecular weight heparin-LMWH), is warranted. We aim to define the optimal prophylactic treatment in the perioperative period in neurooncological patients. A systematic review of the literature was performed in Medline, Embase and Cochrane Library. Thirteen randomized controlled trials (RCTs) were identified, in which physical methods (IPC or GCS) and/or drugs (UFH or LMWHs) were evaluated in perioperative prophylaxis of neurological patients, mostly with brain cancer not treated with anticoagulants for other diseases. The analysis was conducted on a total of 1,932 randomized patients of whom 1,558 had brain tumours. Overall data show a trend of reduction of VTE in patients treated with mechanical methods (IPC or GCS) that should be initiated preoperatively and continued until discharge or longer in case of persistence of risk factors. The addition of enoxaparin starting the day after surgery, significantly reduces clinically manifest VTE, despite an increase in major bleeding events. Further studies are needed to delineate the types of patients with an increase of VTE risk and risk/benefits ratio of physical and pharmacological treatments in the perioperative period.

Entities:  

Mesh:

Year:  2013        PMID: 23543244     DOI: 10.1007/s11060-013-1115-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  23 in total

Review 1.  The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review.

Authors:  L C Marras; W H Geerts; J R Perry
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy.

Authors:  Ajay K Kakkar; Sylvia Haas; Helmut Wolf; Albrecht Encke
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

4.  Mechanical prophylaxis of venous thrombosis in patients undergoing craniotomy: a randomized trial.

Authors:  M N Bucci; S M Papadopoulos; J C Chen; J A Campbell; J T Hoff
Journal:  Surg Neurol       Date:  1989-10

Review 5.  Efficacy of mechanical prophylaxis for venous thromboembolism in patients with brain tumors.

Authors:  Kurtis I Auguste; Alfredo Quiñones-Hinojosa; Mitchel S Berger
Journal:  Neurosurg Focus       Date:  2004-10-15       Impact factor: 4.047

6.  Venous thromboembolism and survival in patients with high-grade glioma.

Authors:  Ralph Simanek; Rainer Vormittag; Marco Hassler; Karl Roessler; Martin Schwarz; Christoph Zielinski; Ingrid Pabinger; Christine Marosi
Journal:  Neuro Oncol       Date:  2007-02-27       Impact factor: 12.300

7.  Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.

Authors:  M T Nurmohamed; A M van Riel; C M Henkens; M M Koopman; G T Que; P d'Azemar; H R Büller; J W ten Cate; J A Hoek; J van der Meer; C van der Heul; A G Turpie; S Haley; A Sicurella; M Gent
Journal:  Thromb Haemost       Date:  1996-02       Impact factor: 5.249

8.  Thromboprophylaxis during chemotherapy after advanced cancer.

Authors:  Giancarlo Agnelli; Melina Verso
Journal:  Thromb Res       Date:  2007       Impact factor: 3.944

9.  Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy.

Authors:  R Loch Macdonald; Chris Amidei; Joseph Baron; Bryce Weir; Frederick Brown; Robert K Erickson; Javad Hekmatpanah; David Frim
Journal:  Surg Neurol       Date:  2003-05

10.  Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control.

Authors:  A G Turpie; J Hirsh; M Gent; D Julian; J Johnson
Journal:  Arch Intern Med       Date:  1989-03
View more
  13 in total

1.  Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.

Authors:  Rifaquat Rahman; Paul J Catalano; David A Reardon; Andrew D Norden; Patrick Y Wen; Eudocia Q Lee; Lakshmi Nayak; Rameen Beroukhim; Ian F Dunn; Alexandra J Golby; Mark D Johnson; E Antonio Chiocca; Elizabeth B Claus; Brian M Alexander; Nils D Arvold
Journal:  J Neurooncol       Date:  2015-06-02       Impact factor: 4.130

2.  Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease.

Authors:  Kristopher T Kimmell; Kevin A Walter
Journal:  J Neurooncol       Date:  2014-08-23       Impact factor: 4.130

3.  The Prophylaxis of Venous Thromboembolism.

Authors:  Albrecht Encke; Sylvia Haas; Ina Kopp
Journal:  Dtsch Arztebl Int       Date:  2016-08-08       Impact factor: 5.594

Review 4.  Venous thromboembolism prophylaxis in brain tumor patients undergoing craniotomy: a meta-analysis.

Authors:  Nasser Alshehri; David J Cote; M Maher Hulou; Ahmad Alghamdi; Ali Alshahrani; Rania A Mekary; Timothy R Smith
Journal:  J Neurooncol       Date:  2016-09-03       Impact factor: 4.130

Review 5.  Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.

Authors:  Lorenzo Rinaldo; Desmond A Brown; Adip G Bhargav; Aaron E Rusheen; Ryan M Naylor; Hannah E Gilder; Dileep D Monie; Stephanie J Youssef; Ian F Parney
Journal:  J Neurosurg       Date:  2019-01-04       Impact factor: 5.115

6.  Venous thromboembolism (VTE) and glioblastoma.

Authors:  Shlomit Yust-Katz; Jacob J Mandel; Jimin Wu; Ying Yuan; Courtney Webre; Tushar A Pawar; Harshad S Lhadha; Mark R Gilbert; Terri S Armstrong
Journal:  J Neurooncol       Date:  2015-05-19       Impact factor: 4.130

7.  American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.

Authors:  Gary H Lyman; Marc Carrier; Cihan Ay; Marcello Di Nisio; Lisa K Hicks; Alok A Khorana; Andrew D Leavitt; Agnes Y Y Lee; Fergus Macbeth; Rebecca L Morgan; Simon Noble; Elizabeth A Sexton; David Stenehjem; Wojtek Wiercioch; Lara A Kahale; Pablo Alonso-Coello
Journal:  Blood Adv       Date:  2021-02-23

Review 8.  Minimally invasive surgery of the anterior skull base: transorbital approaches.

Authors:  Holger G Gassner; Franziska Schwan; Karl-Michael Schebesch
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-07-11

9.  Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.

Authors:  Joeky T Senders; Nicole H Goldhaber; David J Cote; Ivo S Muskens; Hassan Y Dawood; Filip Y F L De Vos; William B Gormley; Timothy R Smith; Marike L D Broekman
Journal:  J Neurooncol       Date:  2017-10-16       Impact factor: 4.130

Review 10.  Clinical management of grade III oligodendroglioma.

Authors:  G Simonetti; P Gaviani; A Botturi; A Innocenti; E Lamperti; A Silvani
Journal:  Cancer Manag Res       Date:  2015-07-27       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.